- Global Pharma News & Resources

PureCircle and Almendra Resolve U.S. Patent Litigation

PureCircle and Almendra Resolve U.S. Patent Litigation

CHICAGO, Jan. 20, 2021 (GLOBE NEWSWIRE) -- PureCircle and Almendra reached an amicable settlement in a patent dispute in the United States relating to Almendra’s Steviarome® products and use thereof.

As of December 31, 2020, PureCircle and Almendra voluntarily resolved the litigation with all claims and counterclaims subsequently being dismissed.

As part of the settlement, Almendra signed a license agreement with PureCircle, which allows Almendra to continue selling its Steviarome® flavor ingredients worldwide. All other terms of the agreement remain confidential.


Jackson Pillow, PureCircle Communications Manager
Phone: +1 (630) 256 8394

Kimberly Hunter, Almendra CFO
Phone: +1 (708) 926-5403

Editor Details

Last Updated: 20-Jan-2021